Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.52 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.49 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.49 |
| ▸ | TLR2 | O60603 | 2/20 | 0.43 |
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.43 |
| ▸ | SIRT1 | Q96EB6 | 2/20 | 0.41 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.41 |
| ▸ | NMT2 | O60551 | 1/20 | 0.41 |
| ▸ | NMT1 | P30419 | 1/20 | 0.41 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.41 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | APLNR | P35414 | 1/20 | 0.41 |
| ▸ | GLP1R | P43220 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17844297 | 1.00 | SLC6A5 (0.52) | SLC6A5ITGB3ITGA2BTLR2NOD1 | |
| SCHEMBL29467847 | 0.94 | SLC6A5 (0.49) | SLC6A5ITGB3ITGA2BTLR2NOD1 | |
| SCHEMBL1163474 | 0.90 | SLC6A5 (0.52) | SLC6A5ITGB3ITGA2BTLR2NOD1 | |
| SCHEMBL322731 | 0.90 | SLC6A5 (0.52) | SLC6A5ITGB3ITGA2BTLR2NOD1 | |
| SCHEMBL31138844 | 0.90 | SLC6A5 (0.50) | SLC6A5ITGB3ITGA2BTLR2NOD1 | |
| SCHEMBL30740007 | 0.89 | APLNR (0.50) | SLC6A5TLR2APLNRGLP1R | |
| SCHEMBL31474897 | 0.89 | APLNR (0.50) | SLC6A5TLR2APLNRGLP1R | |
| SCHEMBL30716920 | 0.87 | SLC6A5 (0.52) | SLC6A5ITGB3ITGA2BTLR2NOD1 | |
| SCHEMBL29941942 | 0.87 | SLC6A5 (0.52) | SLC6A5ITGB3ITGA2BTLR2NOD1 | |
| SCHEMBL29429317 | 0.86 | SLC6A5 (0.48) | SLC6A5ITGB3ITGA2BNOD1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109311939-B | Peptides, compositions comprising said peptides and uses thereof, in particular cosmetic uses | 赛德玛公司 | 2022-10-04 | — | — | CN | disclosed |
| US-11001607-B2 | Peptide, composition comprising said peptide and uses thereof, in particular cosmetic uses | SEDERMA (FR) | 2021-05-11 | — | — | US | disclosed |
| EP-3233210-B1 | TRIPEPTIDES, COMPOSITIONS THEREOF AND THEIR COSMETIC USES | SEDERMA SA (FR) | 2020-02-05 | — | — | EP | disclosed |
| US-20190153030-A1 | PEPTIDE, COMPOSITION COMPRISING SAID PEPTIDE AND USES THEREOF, IN PARTICULAR COSMETIC USES | SEDERMA (FR) | 2019-05-23 | — | — | US | disclosed |
| EP-3468983-A1 | PEPTIDE, COMPOSITION COMPRISING SAID PEPTIDE AND USES THEREOF, IN PARTICULAR COSMETIC USES | SEDERMA (FR) | 2019-04-17 | — | — | EP | disclosed |
| WO-2017216177-A1 | PEPTIDE, COMPOSITION COMPRISING SAID PEPTIDE AND USES THEREOF, IN PARTICULAR COSMETIC USES | SEDERMA (FR) | 2017-12-21 | — | — | WO | disclosed |
| EP-3233210-A1 | TRIPEPTIDES, COMPOSITIONS THEREOF AND THEIR COSMETIC USES | Sederma (FR) | 2017-10-25 | — | — | EP | disclosed |
| WO-2016097966-A1 | TRIPEPTIDES, COMPOSITIONS THEREOF AND THEIR COSMETIC USES | SEDERMA (FR) | 2016-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190153030-A1 | PEPTIDE, COMPOSITION COMPRISING SAID PEPTIDE AND USES THEREOF, IN PARTICULAR COSMETIC USES | PLOD3, CUTA, PLOD1 | SLC6A5 3224/4885ITGB3 2647/4885ITGA2B 2654/4885 |
| US-11001607-B2 | Peptide, composition comprising said peptide and uses thereof, in particular cosmetic uses | PLOD3, CUTA, PLOD1 | SLC6A5 3224/4885ITGB3 2647/4885ITGA2B 2654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.